Promoter and Institution shareholding in Alembic Pharmaceuticals increased YoY and QoQ, while sector averages remained flat, indicating smart money confidence in the stock despite a stagnant sector.

Public shareholding saw a slight decrease QoQ, suggesting retail investors may be retreating, aligning with a contrarian viewpoint.

In contrast to the best and worst performers in the sector, Alembic's positive changes in Promoter and Institution holdings suggest potential resilience against broader sector trends.